Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential roles of Her2/erbB2 in cardiac development and function.

Alejandra Negro1, Bhawanjit K Brar, Kuo-Fen Lee

  • 1Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California 92037-1002, USA.

Recent Progress in Hormone Research
|January 30, 2004
PubMed
Summary

The epidermal growth factor receptor 2 (Her2/erbB2) is crucial for preventing dilated cardiomyopathy. Her2/erbB2 signaling in the heart protects against heart dysfunction, particularly during cancer treatments like Herceptin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thalamic CGRP neurons define a spinothalamic pathway for affective pain.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer.

The New England journal of medicine·2025
Same author

Differential safety profiles of durvalumab monotherapy and durvalumab in combination with tremelimumab in adult patients with advanced cancers.

Journal for immunotherapy of cancer·2025
Same author

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial.

Hepatology (Baltimore, Md.)·2025
Same author

Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC.

Journal of hepatology·2025
Same author

Author Correction: Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer's disease model.

Scientific reports·2025

Area of Science:

  • Cardiovascular Biology
  • Oncology
  • Molecular Biology

Background:

  • Her2/erbB2, a receptor tyrosine kinase, is overexpressed in various cancers, correlating with poor prognosis.
  • Her2/erbB2 is essential for embryonic development, with null mutants exhibiting severe neuronal and cardiac defects.
  • Herceptin treatment for Her2/erbB2-positive cancers can cause cardiac dysfunction, especially when combined with anthracyclines.

Purpose of the Study:

  • To investigate the role of Her2/erbB2 signaling in cardiac function and its implications for dilated cardiomyopathy.
  • To establish mouse models for studying Her2/erbB2's function in cardiac development and adult heart physiology.
  • To explore the mechanisms underlying Herceptin-induced cardiotoxicity and identify potential protective strategies.

Main Methods:

Related Experiment Videos

  • Generated transgenic mice expressing rat erbB2 cDNA in the heart to rescue embryonic lethality.
  • Created cardiac-specific conditional knockout mice to study adult heart function.
  • Assessed cardiac phenotypes, including chamber dilation, wall thinning, and contractility, in erbB2-deficient mice.
  • Investigated the susceptibility of erbB2-deficient cardiac myocytes to anthracycline-induced cytotoxicity.

Main Results:

  • Conditional deletion of erbB2 in adult mice led to dilated cardiomyopathy with chamber dilation, wall thinning, and reduced contractility.
  • erbB2-deficient cardiac myocytes showed increased susceptibility to anthracycline-induced cell death.
  • The study identified a critical role for Her2/erbB2 signaling in maintaining adult cardiac function and preventing cardiomyopathy.

Conclusions:

  • Her2/erbB2 signaling is essential for preventing dilated cardiomyopathy in the adult heart.
  • Mouse models developed in this study are valuable for elucidating the molecular mechanisms of Her2/erbB2 in cardiac regulation.
  • Findings provide insights into mitigating Herceptin-associated cardiotoxicity, potentially expanding its therapeutic use.